Skip to main content

ACG 2024 Annual Meeting Main banner

Icon Legend

This session is not in your Favorites.

This session is in your Favorites. Click again to remove it.

Presentation Icons

ACG Award Winner

ACG Award Winner

ACG Newsworthy Abstract

ACG Newsworthy Abstract

Registration Required

Registration Required

No CME

On-Demand Video

On-Demand Video

Livestream

Back

Feyzullah Aksan, MD

Renaissance School of Medicine, Stony Brook University

Poster(s):

P0625 - Sex-specific Response Patterns to Tricyclic Antidepressants in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Propensity-Matched, Retrospective Cohort Study

Sunday, October 27, 2024
3:30 PM – 7:00 PM ET
P0858 - Comparing Ustekinumab and Vedolizumab in Inflammatory Bowel Disease Patients Exposed to Anti-TNF Agents: A Propensity-Matched, Retrospective Cohort Study

Sunday, October 27, 2024
3:30 PM – 7:00 PM ET
P0859 - Impact of Body Mass Index on the Effectiveness of Biologic Therapies in Inflammatory Bowel Disease: A Retrospective, Propensity Score-Matched Cohort Study

Sunday, October 27, 2024
3:30 PM – 7:00 PM ET
P0860 - Ustekinumab Monotherapy vs Ustekinumab Combined with Immunomodulators in Inflammatory Bowel Disease: A Propensity-Matched, Retrospective Cohort Study

Sunday, October 27, 2024
3:30 PM – 7:00 PM ET
P0861 - Continuing or Discontinuing Mesalamine in Crohn’s Disease? A Multinational, Propensity-Matched, Retrospective Cohort Study

Sunday, October 27, 2024
3:30 PM – 7:00 PM ET
P0862 - Vedolizumab Monotherapy Vs Vedolizumab Combined with Immunomodulators in Inflammatory Bowel Disease: A Propensity-Matched, Retrospective Cohort Study

Sunday, October 27, 2024
3:30 PM – 7:00 PM ET
P0863 - Comparing the Risk of Venous Thromboembolism and Pulmonary Embolism in Inflammatory Bowel Disease Patients Treated With Different Biologics: A Propensity Score-Matched, Retrospective Cohort Study

Sunday, October 27, 2024
3:30 PM – 7:00 PM ET